Phreesia (PHR) Director Executes 10b5-1 Plan: Sale and Option Exercises
Rhea-AI Filing Summary
Michael Weintraub, a director of Phreesia, Inc. (PHR), reported multiple transactions on 08/25/2025 under a Rule 10b5-1 trading plan. The filing shows a sale of 10,000 shares of common stock at $30.00 per share, reducing his direct holdings, and two option-related acquisitions: exercise/receipt of 3,113 shares tied to an $8.03 stock option and 6,887 shares tied to a $4.71 stock option. After these transactions his reported beneficial ownership totals 165,116 shares, including indirect holdings of 30,795 shares through a 2023 Qualified Annuity Trust and 6,703 shares through a Weintraub Family 2017 Irrevocable Trust.
The Form 4 states the trades were effected pursuant to a 10b5-1 plan adopted January 6, 2025, and notes one option is fully vested and exercisable. The filing was signed by a power of attorney on 08/27/2025.
Positive
- Transactions executed under a Rule 10b5-1 plan, indicating preplanned, compliant insider trading
- Exercise of vested options resulting in acquisition of 10,000 shares (3,113 at $8.03 and 6,887 at $4.71), increasing stock ownership at low strike prices
- Detailed disclosure of indirect trust holdings (30,795 and 6,703 shares), improving transparency about beneficial ownership
Negative
- Sale of 10,000 shares at $30.00 reduced direct holdings and represents insider liquidity
- Net change in direct holdings is ambiguous because concurrent sale and exercise transactions offset one another, which may complicate simple interpretation of insider sentiment
Insights
TL;DR: Director sold 10,000 shares and executed options to acquire 10,000 shares under a 10b5-1 plan; net holdings modestly changed.
The report documents a contemporaneous sale and option exercises executed under a Rule 10b5-1 plan, a common mechanism for preplanned insider trades that can reduce timing risk. The sale of 10,000 shares at $30.00 generated proceeds but was offset by acquisitions of 10,000 shares via option exercises at $8.03 and $4.71, respectively. Beneficial ownership remains concentrated with direct and trust holdings totaling 165,116 shares, indicating continued alignment with shareholder interests. No new derivatives exposure was created beyond option exercises already vested.
TL;DR: Transactions were executed under an established 10b5-1 plan, suggesting procedural compliance but still notable insider activity.
The filing explicitly identifies a 10b5-1 plan adopted January 6, 2025, and includes a POA signature, which points to formal governance processes for insider trading compliance. The disclosure of indirect trust holdings provides transparency on control. While the sale is material in absolute share count, the filing does not indicate any unusual timing or governance concerns beyond routine insider liquidity and option exercise activity.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 3,113 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 6,887 | $0.00 | -- |
| Sale | Common Stock | 10,000 | $30.00 | $300K |
| Exercise | Common Stock | 3,113 | $8.03 | $25K |
| Exercise | Common Stock | 6,887 | $4.71 | $32K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 6, 2025. This option is fully vested and exercisable as of the date hereof.
